Transitional Cell Carcinoma of the Renal Pelvis
📧 Sign up to get email alerts when something new happens for Transitional Cell Carcinoma of the Renal Pelvis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-21Clinical Trial Update: ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study [Phase 3]
Phase 3 ENLIGHTED study evaluating endoluminal light-activated treatment for transitional cell cancer of the renal pelvis and ureter has com…
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium [Phase 2]
A Phase 2 trial of Vorinostat for locally recurrent or metastatic urothelial cancers was terminated, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer [Phase 1]
Phase 1 study evaluating the safety and dosing of a three-drug combination (lapatinib with cisplatin and gemcitabine) as first-line therapy …
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: R115777 in Treating Patients With Advanced Bladder Cancer [Phase 2]
Phase 2 trial of R115777 (tipifarnib) for advanced bladder cancer and related transitional cell cancers of the renal pelvis and ureter has c…
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer [Phase 3]
Phase 3 trial evaluating cisplatin plus gemcitabine with or without paclitaxel in stage IV urinary tract cancers has completed. The study in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma [Phase 2]
This ClinicalTrials.gov entry reports a Phase II study of bortezomib (PS-341) in patients with previously treated advanced urothelial tract …
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy [Phase 2]
A completed Phase 2 clinical trial (S0306) evaluating irinotecan in patients with recurrent or refractory advanced transitional cell cancer …